Algo version: 0.98b
Zhejiang Starry is listed at the SHH Exchange
Zhejiang Starry [603520.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Zhejiang Starry stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Zhejiang Starry pays dividends. Last time was Monday 9th of September 2024 where the investors holding the stock on Monday 9th of September 2024 were paid CNY0.05 per share. Over the last 9 times between 2016 and 2024, Zhejiang Starry has paid CNY3.2 with an average of CNY0.36 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Zhejiang Starry 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY16.08, you would have made a loss of CNY-7.86 per share or -48.88%

Yes, the average daily trading liquidity for Zhejiang Starry is CNY3.68 million. You should therefore be able to get in and out of your positions relatively fast.

Zhejiang Starry has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.06, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 2.07%, which is challenging.

We have calculated the inflation risk for Zhejiang Starry to be high [0.8 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.